[1]
2019. Gliclazide reduced oxidative stress, inflammation, and bone loss in an experimental periodontal disease model. Journal of Applied Oral Science. 27, (Jun. 2019), e20180211. DOI:https://doi.org/10.1590/1678-7757-2018-0211.